AstraZeneca.
British-Swedish pharmaceutical company
- Reports this week
- 5
- Active events
- 11
- Connections
- 774
What's happening
Active this week
-
AstraZeneca plans a $2B facility in Tuas, Singapore, while President Shanmugaratnam conducts a state visit to Sweden.Some support1 report
-
A joint venture involving AstraZeneca and Ericsson, supported by Sweden, was formed to launch a Sferical AI supercomputer.Some support2 reports
-
American Cancer Society and AstraZeneca founded BCAM through a partnership between the two organizations.Some support1 report
-
A citizen-led inquiry has begun scrutinizing vaccine injury accountability and high rejection rates in compensation schemes involving AstraZeneca.Some support1 report1 development inside
-
AstraZeneca presented Phase III data for efzimfotase alfa at the American Society for Bone and Mineral Research annual meeting.Some support1 report
-
Jeff Farrow, who previously worked at companies involved in AstraZeneca and Horizon acquisitions, will serve on an Audit Committee.Some support1 report
-
AstraZeneca and Teva Pharmaceutical Industries Limited are being compared as large-cap healthcare companies regarding their revenue and earnings.Some support1 report
-
Biofrontera and AstraZeneca are being compared as healthcare companies for investment.Some support1 report
-
Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.Well supported7 reports
-
A partnership involving AstraZeneca and UNICEF addresses lung health and air pollution challenges in Thailand.Some support1 report
-
In March 2021, the United States loaned vaccine doses to both Mexico and Canada.Some support1 report
Earlier this month
-
Roche terminated Ionis's Huntington's drug program, leading to market scrutiny and investment decisions for all involved pharmaceutical companies.Some support1 report
-
Aetna and AstraZeneca were both accused of denying coverage on October 9, 2026.Some support1 report
-
Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.Some support1 report
-
AstraZeneca is investing in its US footprint to reach revenue goals and addressing a center opening on LinkedIn.Some support1 report
-
AstraZeneca and Tarsus Pharmaceuticals, Inc. are two healthcare companies that are currently competing for investment.Some support1 report
-
Dr Koh's professional background includes senior roles at GSK and AstraZeneca, and he is an Honorary Consultant in the NHS.Some support2 reports
-
AstraZeneca and Tvardi Therapeutics are being compared as healthcare companies.Some support1 report
-
AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Some support3 reports
-
Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Well supported4 reports12 developments inside
-
AstraZeneca, AMPATH, and Lancet Laboratories launched the Helix Project in South Africa for advanced genomic testing.Some support1 report
-
AstraZeneca supplies HVO to EcoCeres for manufacturing backup power.Some support1 report
-
Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.Well supported3 reports1 development inside
-
Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.Some support1 report
-
Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.Some support1 report
-
Both the Netherlands and AstraZeneca were discussed as potential undervalued international investments.Some support1 report
-
Multiple major pharmaceutical companies were identified as industry peers for growth during a capital markets day.Some support1 report1 development inside
-
AbbVie, AstraZeneca, and Bristol-Myers Squibb collaborated on the AISB Bind AI initiative.Some support2 reports
-
The NHS in England has cleared Enhertu for use, strengthening its access and availability.Some support2 reports
-
AstraZeneca is supporting a food access initiative taking place in Queens.Some support1 report
-
Oklahoma State Law seeks to expand patient access to discounted drugs and faces lawsuits challenging the 340B program scope.Some support2 reports
-
Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.Some support2 reports1 development inside
-
Unpaid bills totaling R1bn are causing service suspensions in the Eastern Cape, affecting operations of AstraZeneca and Sandoz.Some support1 report
-
Tempus AI has named AstraZeneca as a customer, and Morgan Stanley boosted its revenue outlook.Some support2 reports
One to three months ago
-
Analysts are monitoring the performance and pipeline risks of AstraZeneca, following concurrent stake purchases and increased holdings by Bank of America.Some support1 report1 development inside
-
AstraZeneca announced a major €26 billion investment in Wuxi, China, while simultaneously facing an underperform rating and tracking global oil prices.Some support1 report
-
AstraZeneca is supplying a nasal spray vaccine to Ireland.Some support1 report
-
A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.Some support1 report
-
Amit Shah oversaw anti-terror operations in Jammu and Kashmir, while simultaneously, an investment upgraded production bases in Wuxi.Some support1 report
-
Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.Some support3 reports4 developments inside
-
AstraZeneca's drug was tested in collaboration with Pfizer's drug.Some support1 report
-
AstraZeneca is facing market pressure following a clinical trial failure, leading to a decline in its stock value.Some support1 report1 development inside
-
Following AstraZeneca's clinical trial failure, investor sentiment has turned negative, leading Stifel to cut the price target for Olema Pharmaceuticals.Some support1 report
-
Ayala Healthcare Holdings Inc. and Healthway Medical Network partner with AstraZeneca to strengthen clinical trial capabilities in Metro Manila.Some support1 report
-
Daiichi Sankyo and AstraZeneca partnered on the development of the Enhertu drug, which was tested in Etcamah trials combined with Ibrance as a UK drugmaker.Some support2 reports
-
AstraZeneca and Innate Pharma S.A. are collaborating on developing a lead pharmaceutical program.Some support1 report
-
Daiichi Sankyo co-developed datopotamab deruxtecan with partners, and Jim Cramer compared AstraZeneca to Novartis.Some support2 reports
-
AstraZeneca and Dell EMC are both employing senior leadership roles within their Human Resources departments.Some support1 report
-
AstraZeneca leveraged an investigator's assessment regarding the clinical benefit of its treatments.Some support1 report
-
Petra Hamerlik, who previously worked at AstraZeneca plc, has been appointed as the Chair of Translational Neuro-Oncology at the University of Manchester.Some support1 report
-
Amgen and AstraZeneca partnered on a Phase 3 CROSSING trial for the drug TEZSPIRE.Some support3 reports1 development inside
-
Amgen and AstraZeneca co-developed the severe asthma drug TEZSPIRE, prompting an analyst to raise the price target.Some support2 reports
-
Amgen and AstraZeneca announced a collaborative development of a combination therapy.Some support2 reports1 development inside
-
Joint drug trial success boosts Amgen stock.Some support1 report
-
AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.Some support1 report2 developments inside
-
AstraZeneca and GSK, along with Aurora Cannabis Inc., are involved in hiring Faris El Refaie for global commercial leadership, gaining experience in the pharmaceutical sector.Some support3 reports
-
Cramer provided market sentiment and investment advice regarding company trials involving AstraZeneca and Trinity Industries.Some support1 report
-
AstraZeneca and Novavax are pursuing technology transfer to enable local vaccine production.Some support1 report
-
George Godfrey, formerly of AstraZeneca, has been appointed Senior Director at Novo Nordisk.Some support1 report
-
AstraZeneca released a press release citing Dr. Frank Sciurba.Some support6 reports
No events began in the chosen period. Widen it, or reset.
What's reaching AstraZeneca
Events traced to AstraZeneca, step by step, newest first- AstraZeneca may expand clinical trial capabilities across IndiaAstraZeneca may expand its global clinical trial footprint and market access in IndiaPossible
- Competitors' rapid biologic advances may challenge AstraZeneca's market positionIncreased investment in biologics may intensify competitive pressure on AstraZenecaPossible
- AstraZeneca may face pressure to accelerate Lyme disease researchAstraZeneca may face pressure to accelerate Lyme disease researchPossible
- AstraZeneca stock dips amid EU approval news and market uncertaintyAstraZeneca stock fell 0.32% despite Enhertu receiving EU approval recommendation.Reported
Explainers that pass through AstraZeneca
AstraZeneca is a step on the way to someone elseAround AstraZeneca this week
News at the entities that move AstraZeneca most-
Bristol-Myers Squibb TransactionalBristol-Myers Squibb and Özlem Türeci presented late-stage oncology pipeline data and joint development activity in Mainz.Moves AstraZeneca
-
London Stock Exchange StructuralCarclo plc shares are quoted on the Main Market of the London Stock Exchange.Moves AstraZeneca
-
FDA StructuralThe FDA approved GSK's Jemperli drug, while Memorial Sloan Kettering Cancer Center was involved in the AZUR-1 trial.Moves AstraZeneca
-
European Medicines Agency StructuralGlenn attended a congress in Amsterdam and participated in a panel with an official from the European Medicines Agency.Moves AstraZeneca
-
Eli Lilly and Company OperationalMedicare coverage is driving growth in the obesity drug market, leading to raised price targets for Eli Lilly.Moves AstraZeneca
-
AbbVie OperationalKori Wallace was appointed vice president at AbbVie.Moves AstraZeneca
Connections
The 40 strongest of 774, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Bristol-Myers Squibb Transactional
The two pharmaceutical companies are engaged in high-stakes merger talks regarding a potential combined entity valued at approximately $400 billion.
-
Daiichi Sankyo Structural
The companies are engaged in a deep, ongoing partnership for the joint development and commercialization of advanced cancer treatments, including Enhertu and Datroway.
-
Ionis Pharmaceuticals Transactional
The companies formed a joint development partnership for the Wainua gene-silencing drug candidate, which ultimately failed in late-stage clinical trials.
-
Pascal Soriot Structural
Pascal Soriot holds the executive leadership role as Chief Executive Officer of AstraZeneca.
-
Eli Lilly and Company Operational
Eli Lilly and AstraZeneca are active competitors in the pharmaceutical market, vying for market share in oncology and obesity.
-
Compugen Ltd. Structural
Compugen licenses technology and antibodies to AstraZeneca, enabling the development of the drug Rilvegostomig.
-
AbbVie Operational
AbbVie and AstraZeneca are direct competitors in oncology and dyslipidemia, while also engaging in strategic collaborations, such as AI initiatives.
-
Tempus Operational
Tempus and AstraZeneca are engaged in a partnership to jointly develop an oncology foundation model, supported by a $200M data licensing deal.
Show all 40 connections
-
Albemarle County Structural
AstraZeneca is establishing a major manufacturing campus in Albemarle County with a secured investment of $4.5 billion.
-
London Stock Exchange Structural
AstraZeneca is formally listed on the London Stock Exchange, making the exchange critical for its valuation and market operations.
-
Pfizer Operational
Pfizer and AstraZeneca are active competitors in major biopharma markets, including oncology and functional dyspepsia.
-
FibroGen (United States) Transactional
AstraZeneca acquired FibroGen China and its assets through a series of sales and acquisitions.
-
Merck Operational
AstraZeneca and Merck actively compete in the oncology space while simultaneously engaging in strategic partnerships and profit-sharing agreements.
-
FDA Structural
FDA regulates AstraZeneca's drug development, requiring approvals and designations for market access.
-
Hutchison MediPharma Limited Structural
AstraZeneca and Hutchison MediPharma are engaged in a formal joint development and commercialization partnership for the drug savolitinib.
-
GSK Operational
GSK and AstraZeneca are direct competitors in the pharmaceutical market, facing rivalry in oncology and respiratory sectors.
-
Daiichi Sankyo (United Kingdom) Operational
AstraZeneca and Daiichi Sankyo maintain a formal partnership and licensing agreement for the drug Enhertu.
-
Morgan Stanley Operational
Morgan Stanley provides financial ratings, stock advice, and investment banking services for AstraZeneca.
-
Frank Sciurba Structural
Frank Sciurba serves as the Chief Investigator for AstraZeneca's LUNA programme, linking his expertise to the company's research announcements.
-
Royal Bank of Canada Structural
Royal Bank of Canada is increasing its financial stake and providing investment coverage on AstraZeneca stock.
-
American Society of Clinical Oncology Operational
AstraZeneca utilizes the ASCO Annual Meeting as a platform for presenting clinical trial results and engaging with the oncology scientific community.
-
Amundi Transactional
Amundi repeatedly increased its financial holdings and stake in AstraZeneca shares.
-
London Operational
AstraZeneca is headquartered in London, and its corporate and stock market activities directly influence the city's financial ecosystem.
-
Sanofi Operational
Sanofi and AstraZeneca are actively collaborating on the production and scaling of the drug Beyfortus.
-
IONQ Operational
IONQ and AstraZeneca maintain an active partnership focused on leveraging quantum computing for accelerating drug discovery and computational chemistry workflows.
-
Alnylam Pharmaceuticals Operational
The companies are direct competitors in the ATTR-CM indication while also maintaining a formal partnership on drug development.
-
Union Investment Structural
Union Investment is a current shareholder in AstraZeneca, creating a dependency structure.
-
Johnson & Johnson Operational
Johnson & Johnson and AstraZeneca are major pharmaceutical companies engaged in direct competition within the oncology and immunology markets.
-
European Medicines Agency Structural
The European Medicines Agency reviews AstraZeneca's products for market approval.
-
Fusion Pharmaceuticals Structural
Fusion Pharmaceuticals was acquired by AstraZeneca in 2024 for approximately US$2 billion.
-
Biogen Operational
The two companies are actively competing in the market, facing pressure to meet ambitious revenue targets.
-
Daiichi Operational
AstraZeneca and Daiichi are engaged in a formal partnership for joint drug development and marketing.
-
SEC Structural
AstraZeneca is subject to financial reporting and regulatory oversight by the SEC.
-
CSPC Pharmaceutical Group Operational
AstraZeneca and CSPC are actively collaborating on AI drug discovery and experimental treatments for chronic diseases, including kidney disease.
-
Sophia Genetics Operational
AstraZeneca and Sophia Genetics have formed a multi-year partnership to leverage AI for breast cancer therapies.
-
Novo Nordisk Operational
The two companies are direct, active competitors, specifically challenging each other in the obesity drug market.
-
Summit Therapeutics Transactional
AstraZeneca is actively negotiating and partnering with Summit Therapeutics regarding lung cancer drug development and licensing.
-
Court of Justice of the European Union Structural
AstraZeneca operates as a company subject to the jurisdiction, rulings, and oversight of the Court of Justice of the European Union.
-
Hoffmann-La Roche Operational
Hoffmann-La Roche and AstraZeneca are direct competitors in the pharmaceutical market, facing shared market pressures and rivalry in drug development.
-
Edge Structural
Edge was employed as a scientist at AstraZeneca.
History
Events by the month they beganOctober 2026
15 events- AstraZeneca plans a $2B facility in Tuas, Singapore, while President Shanmugaratnam conducts a state visit to Sweden.
- American Cancer Society and AstraZeneca founded BCAM through a partnership between the two organizations.
- AstraZeneca presented Phase III data for efzimfotase alfa at the American Society for Bone and Mineral Research annual meeting.
- Jeff Farrow, who previously worked at companies involved in AstraZeneca and Horizon acquisitions, will serve on an Audit Committee.
- AstraZeneca and Teva Pharmaceutical Industries Limited are being compared as large-cap healthcare companies regarding their revenue and earnings.
- Biofrontera and AstraZeneca are being compared as healthcare companies for investment.
- A partnership involving AstraZeneca and UNICEF addresses lung health and air pollution challenges in Thailand.
- In March 2021, the United States loaned vaccine doses to both Mexico and Canada.
- Roche terminated Ionis's Huntington's drug program, leading to market scrutiny and investment decisions for all involved pharmaceutical companies.
- Aetna and AstraZeneca were both accused of denying coverage on October 9, 2026.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.
- AstraZeneca is investing in its US footprint to reach revenue goals and addressing a center opening on LinkedIn.
- AstraZeneca and Tarsus Pharmaceuticals, Inc. are two healthcare companies that are currently competing for investment.
- Dr Koh's professional background includes senior roles at GSK and AstraZeneca, and he is an Honorary Consultant in the NHS.
- AstraZeneca and Tvardi Therapeutics are being compared as healthcare companies.
September 2026
35 events- AstraZeneca, AMPATH, and Lancet Laboratories launched the Helix Project in South Africa for advanced genomic testing.
- AstraZeneca supplies HVO to EcoCeres for manufacturing backup power.
- Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.
- Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.
- Both the Netherlands and AstraZeneca were discussed as potential undervalued international investments.
- Multiple major pharmaceutical companies were identified as industry peers for growth during a capital markets day.
- AbbVie, AstraZeneca, and Bristol-Myers Squibb collaborated on the AISB Bind AI initiative.
- The NHS in England has cleared Enhertu for use, strengthening its access and availability.
- AstraZeneca is supporting a food access initiative taking place in Queens.
- Oklahoma State Law seeks to expand patient access to discounted drugs and faces lawsuits challenging the 340B program scope.
- Ionis Pharmaceuticals is seeking FDA approval for its treatments for Alexander disease, including Tryngolza, and has formed new partnerships with AstraZeneca and Hoffmann-La Roche.
- Unpaid bills totaling R1bn are causing service suspensions in the Eastern Cape, affecting operations of AstraZeneca and Sandoz.
- Tempus AI has named AstraZeneca as a customer, and Morgan Stanley boosted its revenue outlook.
- AstraZeneca announced a major €26 billion investment in Wuxi, China, while simultaneously facing an underperform rating and tracking global oil prices.
- AstraZeneca is supplying a nasal spray vaccine to Ireland.
- A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.
- Amit Shah oversaw anti-terror operations in Jammu and Kashmir, while simultaneously, an investment upgraded production bases in Wuxi.
- AstraZeneca's drug was tested in collaboration with Pfizer's drug.
- Following AstraZeneca's clinical trial failure, investor sentiment has turned negative, leading Stifel to cut the price target for Olema Pharmaceuticals.
- Ayala Healthcare Holdings Inc. and Healthway Medical Network partner with AstraZeneca to strengthen clinical trial capabilities in Metro Manila.
- Daiichi Sankyo and AstraZeneca partnered on the development of the Enhertu drug, which was tested in Etcamah trials combined with Ibrance as a UK drugmaker.
- AstraZeneca and Innate Pharma S.A. are collaborating on developing a lead pharmaceutical program.
- Daiichi Sankyo co-developed datopotamab deruxtecan with partners, and Jim Cramer compared AstraZeneca to Novartis.
- AstraZeneca and Dell EMC are both employing senior leadership roles within their Human Resources departments.
- AstraZeneca leveraged an investigator's assessment regarding the clinical benefit of its treatments.
- Petra Hamerlik, who previously worked at AstraZeneca plc, has been appointed as the Chair of Translational Neuro-Oncology at the University of Manchester.
- Amgen and AstraZeneca co-developed the severe asthma drug TEZSPIRE, prompting an analyst to raise the price target.
- Amgen and AstraZeneca announced a collaborative development of a combination therapy.
- Joint drug trial success boosts Amgen stock.
- AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.
- AstraZeneca and GSK, along with Aurora Cannabis Inc., are involved in hiring Faris El Refaie for global commercial leadership, gaining experience in the pharmaceutical sector.
- Cramer provided market sentiment and investment advice regarding company trials involving AstraZeneca and Trinity Industries.
- AstraZeneca and Novavax are pursuing technology transfer to enable local vaccine production.
- George Godfrey, formerly of AstraZeneca, has been appointed Senior Director at Novo Nordisk.
- AstraZeneca released a press release citing Dr. Frank Sciurba.
August 2026
2 eventsShow 2 earlier months
July 2026
2 eventsJune 2026
6 events- A joint venture involving AstraZeneca and Ericsson, supported by Sweden, was formed to launch a Sferical AI supercomputer.
- A citizen-led inquiry has begun scrutinizing vaccine injury accountability and high rejection rates in compensation schemes involving AstraZeneca.
- Jefferies Financial Group provided analyst ratings for AstraZeneca stock on June 20, 2026.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.
- Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.